RETINAL DEGENERATION
Clinical trials for RETINAL DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new RETINAL DEGENERATION trials appear
Sign up with your email to follow new studies for RETINAL DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human trial launches for gene therapy targeting rare blindness disorder
Disease control Not yet recruitingThis early-stage trial tests a single dose of AXV-101, a gene therapy, in 12 children aged 4 to 17 with Bardet-Biedl syndrome type 1 (BBS1) who have vision loss. The main goal is to see if the treatment is safe and tolerable, and to find the right dose. Participants will have eye…
Matched conditions: RETINAL DEGENERATION
Phase: EARLY_PHASE1 • Sponsor: Axovia Therapeutics • Aim: Disease control
Last updated May 17, 2026 10:05 UTC
-
Magnetic pulses to the brain aim to restore sight in new trial
Symptom relief Not yet recruitingThis study tests whether transcranial magnetic stimulation (TMS) can improve vision in adults aged 45–70 with severe retinal degeneration. Half of the 136 participants will receive real TMS, and the other half will receive a sham (fake) treatment for five days. Researchers will t…
Matched conditions: RETINAL DEGENERATION
Phase: NA • Sponsor: Shanghai High Myopia Study Group • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC